Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arsura E. L., Bick A., Brunner N. G., Grob D. Effects of repeated doses of intravenous immunoglobulin in myasthenia gravis. Am J Med Sci. 1988 May;295(5):438–443. doi: 10.1097/00000441-198805000-00005. [DOI] [PubMed] [Google Scholar]
- Arsura E. L., Bick A., Brunner N. G., Namba T., Grob D. High-dose intravenous immunoglobulin in the management of myasthenia gravis. Arch Intern Med. 1986 Jul;146(7):1365–1368. [PubMed] [Google Scholar]
- Cook L., Howard J. F., Jr, Folds J. D. Immediate effects of intravenous IgG administration on peripheral blood B and T cells and polymorphonuclear cells in patients with myasthenia gravis. J Clin Immunol. 1988 Jan;8(1):23–31. doi: 10.1007/BF00915153. [DOI] [PubMed] [Google Scholar]
- Cosi V., Lombardi M., Piccolo G., Erbetta A. Treatment of myasthenia gravis with high-dose intravenous immunoglobulin. Acta Neurol Scand. 1991 Aug;84(2):81–84. doi: 10.1111/j.1600-0404.1991.tb04912.x. [DOI] [PubMed] [Google Scholar]
- Drachman D. B., McIntosh K. R., Reim J., Balcer L. Strategies for treatment of myasthenia gravis. Ann N Y Acad Sci. 1993 Jun 21;681:515–528. doi: 10.1111/j.1749-6632.1993.tb22935.x. [DOI] [PubMed] [Google Scholar]
- Dwyer J. M. Manipulating the immune system with immune globulin. N Engl J Med. 1992 Jan 9;326(2):107–116. doi: 10.1056/NEJM199201093260206. [DOI] [PubMed] [Google Scholar]
- Ferrero B., Durelli L., Cavallo R., Dutto A., Aimo G., Pecchio F., Bergamasco B. Therapies for exacerbation of myasthenia gravis. The mechanism of action of intravenous high-dose immunoglobulin G. Ann N Y Acad Sci. 1993 Jun 21;681:563–566. doi: 10.1111/j.1749-6632.1993.tb22941.x. [DOI] [PubMed] [Google Scholar]
- Gajdos P., Outin H., Elkharrat D., Brunel D., de Rohan-Chabot P., Raphael J. C., Goulon M., Goulon-Goeau C., Morel E. High-dose intravenous gammaglobulin for myasthenia gravis. Lancet. 1984 Feb 18;1(8373):406–407. doi: 10.1016/s0140-6736(84)90469-0. [DOI] [PubMed] [Google Scholar]
- Meiner Z., Ben-Hur T., River Y., Reches A. Aseptic meningitis as complication of intravenous immunoglobulin therapy for myasthenia gravis. J Neurol Neurosurg Psychiatry. 1993 Jul;56(7):830–831. doi: 10.1136/jnnp.56.7.830-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pascuzzi R. M., Coslett H. B., Johns T. R. Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients. Ann Neurol. 1984 Mar;15(3):291–298. doi: 10.1002/ana.410150316. [DOI] [PubMed] [Google Scholar]
- Verma P., Oger J. Treatment of acquired autoimmune myasthenia gravis: a topic review. Can J Neurol Sci. 1992 Aug;19(3):360–375. [PubMed] [Google Scholar]